ALPS Medical Breakthroughs ETF
SBIO
66 hedge funds and large institutions have $79.4M invested in ALPS Medical Breakthroughs ETF in 2026 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 14 closing their positions.
78% more capital invested
Capital invested by funds: $44.6M → $79.4M (+$34.8M)
57% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 14
8.63% more ownership
Funds ownership: 33.71% → 42.34% (+8.6%)
8% more funds holding
Funds holding: 61 → 66 (+5)
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$17.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.27M |
| 3 |
FFAS
FIG Financial Advisory Services
Oklahoma City,
Oklahoma
|
+$1.38M |
| 4 |
EH
Equitable Holdings
New York
|
+$840K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$486K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.18M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
-$1.46M |
| 3 |
SFS
Strategic Financial Services
Utica,
New York
|
-$1.3M |
| 4 |
GS
GTS Securities
Miami,
Florida
|
-$996K |
| 5 |
VF
Virtu Financial
New York
|
-$927K |
SBIO Hedge Fund Activity: Q2 2026 in Review
66 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2026, worth a combined $79.4M — up 78% from $44.6M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SBIO positions and 14 closed out — a net gain of 8 holders — while 15 added to existing stakes and 15 trimmed.
The largest buyer was Bank of America, adding an estimated $17.6M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $3.18M sold.
- 66 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2026, up from 61 in Q1 2026.
- Funds reported $79.4M of ALPS Medical Breakthroughs ETF stock for Q2 2026, up 78% quarter-over-quarter.
- 22 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2026 and 14 closed out, a net change of +8 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q2 2026 was Bank of America, an estimated $17.6M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q2 2026 was Susquehanna International Group, an estimated $3.18M sold.
Based on aggregated 13F filings for Q2 2026.